Impact of NPM1 mutation subtypes on treatment outcome in AML: The Lyon-University Hospital experience

被引:4
作者
Heiblig, Mael [1 ]
Sujobert, Pierre [2 ]
Hayette, Sandrine [2 ]
Balsat, Marie [1 ]
Elhamri, Mohamed [1 ]
Salles, Gilles [1 ]
Thomas, Xavier [1 ]
机构
[1] Lyon Sud Hosp, Dept Hematol, Hosp Civils Lyon, Pierre Benite, France
[2] Lyon Sud Hosp, Mol Biol Lab, Hosp Civils Lyon, Pierre Benite, France
关键词
ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; NUCLEOPHOSMIN; RISK;
D O I
10.1016/j.leukres.2018.11.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:29 / 32
页数:4
相关论文
共 19 条
  • [1] Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia
    Alpermann, Tamara
    Schnittger, Susanne
    Eder, Christiane
    Dicker, Frank
    Meggendorfer, Manja
    Kern, Wolfgang
    Schmid, Christoph
    Aul, Carlo
    Staib, Peter
    Wendtner, Clemens-Martin
    Schmitz, Norbert
    Haferlach, Claudia
    Haferlach, Torsten
    [J]. HAEMATOLOGICA, 2016, 101 (02) : E55 - E58
  • [2] Evaluation Of Different NPM1 Mutations In AML Patients According To Clinical, Cytogenetic and Molecular Features and Impact On Outcome
    Alpermann, Tamara
    Haferlach, Claudia
    Dicker, Frank
    Eder, Christiane
    Kohlmann, Alexander
    Kern, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    [J]. BLOOD, 2013, 122 (21)
  • [3] Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group
    Balsat, Marie
    Renneville, Aline
    Thomas, Xavier
    de Botton, Stephane
    Caillot, Denis
    Marceau, Alice
    Lemasle, Emilie
    Marolleau, Jean-Pierre
    Nibourel, Olivier
    Berthon, Celine
    Raffoux, Emmanuel
    Pigneux, Arnaud
    Rodriguez, Celine
    Vey, Norbert
    Cayuela, Jean-Michel
    Hayette, Sandrine
    Braun, Thorsten
    Coude, Marie Magdeleine
    Terre, Christine
    Celli-Lebras, Karine
    Dombret, Herve
    Preudhomme, Claude
    Boissel, Nicolas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) : 185 - +
  • [4] Co-occurrence of FLT3-TKD and NPM1 mutations defines a highly favorable prognostic AML group
    Boddu, Prajwal
    Kantarjian, Hagop
    Borthakur, Gautam
    Kadia, Tapan
    Daver, Naval
    Pierce, Sherry
    Andreeff, Michael
    Ravandi, Farhad
    Cortes, Jorge
    Kornblau, Steven M.
    [J]. BLOOD ADVANCES, 2017, 1 (19) : 1546 - 1550
  • [5] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
    Doehner, Hartmut
    Estey, Elihu H.
    Amadori, Sergio
    Appelbaum, Frederick R.
    Buechner, Thomas
    Burnett, Alan K.
    Dombret, Herve
    Fenaux, Pierre
    Grimwade, David
    Larson, Richard A.
    Lo-Coco, Francesco
    Naoe, Tomoki
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    Sanz, Miguel A.
    Sierra, Jorge
    Tallman, Martin S.
    Loewenberg, Bob
    Bloomfield, Clara D.
    [J]. BLOOD, 2010, 115 (03) : 453 - 474
  • [6] Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
    Döhner, K
    Schlenk, RF
    Habdank, M
    Scholl, C
    Rücker, FG
    Corbacioglu, A
    Bullinger, L
    Fröhling, S
    Döhner, H
    [J]. BLOOD, 2005, 106 (12) : 3740 - 3746
  • [7] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
    Falini, B
    Mecucci, C
    Tiacci, E
    Alcalay, M
    Rosati, R
    Pasqualucci, L
    La Starza, R
    Diverio, D
    Colombo, E
    Santucci, A
    Bigerna, B
    Pacini, R
    Pucciarini, A
    Liso, A
    Vignetti, M
    Fazi, P
    Meani, N
    Pettirossi, V
    Saglio, G
    Mandelli, F
    Lo-Coco, F
    Pelicci, P
    Martelli, MF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 254 - 266
  • [8] Nucleophosmin mutations in acute myeloid leukemia: A tale of protein unfolding and mislocalization
    Federici, Luca
    Falini, Brunangelo
    [J]. PROTEIN SCIENCE, 2013, 22 (05) : 545 - 556
  • [9] Nucleophosmin and cancer
    Grisendi, Silvia
    Mecucci, Cristina
    Falini, Brunangelo
    Pandolfi, Pier Paolo
    [J]. NATURE REVIEWS CANCER, 2006, 6 (07) : 493 - 505
  • [10] AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
    Haferlach, Claudia
    Mecucci, Cristina
    Schnittger, Susanne
    Kohlmann, Alexander
    Mancini, Marco
    Cuneo, Antonio
    Testoni, Nicoletta
    Rege-Cambrin, Giovanna
    Santucci, Antonella
    Vignetti, Marco
    Fazi, Paola
    Martelli, Maria Paola
    Haferlach, Torsten
    Falini, Brunangelo
    [J]. BLOOD, 2009, 114 (14) : 3024 - 3032